Want to see HK:0897 full AI Analyst Report?
Total Valuation
Wai Yuen Tong Medicine Holdings Limited has a market cap or net worth of HK$334.31M. The enterprise value is HK$560.58.
Market CapHK$334.31M
Enterprise ValueHK$560.58
Share Statistics
Wai Yuen Tong Medicine Holdings Limited has 1,114,382,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,114,382,900
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Wai Yuen Tong Medicine Holdings Limited’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is -1.16%.
Return on Equity (ROE)<0.01
Return on Assets (ROA)<0.01
Return on Invested Capital (ROIC)-1.16%
Return on Capital Employed (ROCE)-0.01
Revenue Per Employee989.06K
Profits Per Employee5.25K
Employee Count691
Asset Turnover0.42
Inventory Turnover1.42
Valuation Ratios
The current PE Ratio of Wai Yuen Tong Medicine Holdings Limited is 88.9. Wai Yuen Tong Medicine Holdings Limited’s PEG ratio is -2.14.
PE Ratio88.9
PS Ratio0.54
PB Ratio0.31
Price to Fair Value0.31
Price to FCF6.52
Price to Operating Cash Flow3.56
PEG Ratio-2.14
Income Statement
In the last 12 months, Wai Yuen Tong Medicine Holdings Limited had revenue of 683.44M and earned 3.99M in profits. Earnings per share was <0.01.
Revenue683.44M
Gross Profit361.93M
Operating Income-17.10M
Pretax Income3.63M
Net Income3.99M
EBITDA67.05M
Earnings Per Share (EPS)<0.01
Cash Flow
In the last 12 months, operating cash flow was 99.70M and capital expenditures -13.49M, giving a free cash flow of 86.21M billion.
Operating Cash Flow99.70M
Free Cash Flow86.21M
Free Cash Flow per Share0.08
Dividends & Yields
Wai Yuen Tong Medicine Holdings Limited pays an annual dividend of HK$0.03, resulting in a dividend yield of 7.5%
Dividend Per ShareHK$0.03
Dividend Yield7.5%
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.38
52-Week Price Change3.23%
50-Day Moving Average0.31
200-Day Moving Average0.36
Relative Strength Index (RSI)46.29
Average Volume (3m)632.59K
Important Dates
Wai Yuen Tong Medicine Holdings Limited upcoming earnings date is Dec 1, 2026, TBA (Confirmed).
Last Earnings DateJun 25, 2026
Next Earnings DateDec 1, 2026
Ex-Dividend Date―
Financial Position
Wai Yuen Tong Medicine Holdings Limited as a current ratio of 1.40, with Debt / Equity ratio of 23.63%
Current Ratio1.40
Quick Ratio0.87
Debt to Market Cap0.75
Net Debt to EBITDA2.18
Interest Coverage Ratio-0.97
Taxes
In the past 12 months, Wai Yuen Tong Medicine Holdings Limited has paid -445.00K in taxes.
Income Tax-445.00K
Effective Tax Rate-0.12
Enterprise Valuation
Wai Yuen Tong Medicine Holdings Limited EV to EBITDA ratio is 7.71, with an EV/FCF ratio of 9.08.
EV to Sales0.76
EV to EBITDA7.71
EV to Free Cash Flow9.08
EV to Operating Cash Flow7.34
Balance Sheet
Wai Yuen Tong Medicine Holdings Limited has HK$147.44M in cash and marketable securities with HK$279.29M in debt, giving a net cash position of -HK$131.85M billion.
Cash & Marketable SecuritiesHK$147.44M
Total DebtHK$279.29M
Net Cash-HK$131.85M
Net Cash Per Share-HK$0.12
Tangible Book Value Per ShareHK$1.05
Margins
Gross margin is 52.96%, with operating margin of -2.50%, and net profit margin of 0.58%.
Gross Margin52.96%
Operating Margin-2.50%
Pretax Margin0.53%
Net Profit Margin0.58%
EBITDA Margin9.81%
EBIT Margin-2.50%
Analyst Forecast
The average price target for Wai Yuen Tong Medicine Holdings Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-8.30%
EPS Growth Forecast-44.44%